Matrixyl (palmitoyl pentapeptide)
Matrixyl (palmitoyl pentapeptide)
Quantité
Commande minimum de: 200 boxsLivraison
Le fournisseur expédiera dans 3–15 jours après confirmation du paiement.
Les marchandises seront expédiées depuis le port de United Kingdom, China
L'expédition est proposée selon les conditions FOB — le fournisseur couvre les frais jusqu'au port de destination.
Paiement : Western Union
Échantillon disponible · $380.00/échantillon
Euromart Suppliers protection de commande
Chaque paiement que vous effectuez est sécurisé avec un cryptage SSL strict et des protocoles de protection des données PCI DSS
Effectuez des retours locaux gratuits pour les défauts sur les achats éligibles
Réclamez un remboursement si votre commande n'est pas expédiée, est manquante ou arrive avec des problèmes de produit
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
Matrixyl (Palmitoyl Pentapeptide‑4) is a trademarked cosmetic peptide developed by Sederma/Croda, designed to stimulate collagen and elastin synthesis, reduce wrinkles, and improve skin firmness. It is available in several commercial configurations such as Matrixyl®, Matrixyl® 3000, Matrixyl® Synthe’6, and Matrixyl® Morphomics®.
KEY FEATURES
Collagen stimulation: Boosts synthesis of collagen types I, III, and IV by up to 350% in vitro.
Fibronectin & elastin: Increases production by up to 200%, improving elasticity.
Wrinkle reduction: Clinical studies show visible decreases in wrinkle depth and fine lines.
Skin repair: Supports wound healing and dermal regeneration.
Non‑irritating: Gentler than retinoids, compatible with other actives.
TECHNICAL SPECIFICATIONS
INCI Name (original Matrixyl): Palmitoyl Pentapeptide‑4 (Pal‑KTTKS).
Sequence: Lys‑Thr‑Thr‑Lys‑Ser (KTTKS) with palmitoyl fatty acid chain for enhanced penetration.
Molecular Weight: ~805 Da
Form: Cosmetic grade peptide, ≥95% purity, typically supplied as powder or solution
Solubility: Water‑soluble when formulated with carriers.
Recommended Concentration: 3–5% in topical formulations (serums, creams, lotions)
Application Protocol: Twice daily; results visible after 4–8 weeks
Storage: 4–7 °C, stable for 24 months (Matrixyl 3000)
AVALAIBLE CONFIGURATION
Matrixyl® (original) — Palmitoyl Pentapeptide‑4. This was the first generation peptide, proven to stimulate collagen types I, III, and IV, reduce wrinkles, and improve skin firmness.
Matrixyl® 3000 — A blend of Palmitoyl Tripeptide‑1 and Palmitoyl Tetrapeptide‑7. It enhances collagen and elastin production while also reducing inflammation, making it one of the most widely used versions in serums.
Matrixyl® Synthe’6 — Palmitoyl Tripeptide‑38. This variant targets dermal matrix repair, filling deeper wrinkles and stimulating multiple structural proteins including collagen, fibronectin, and hyaluronic acid.
Matrixyl® Morphomics® — A newer proprietary peptide complex. It focuses on sagging and facial contours, marketed as a solution for “morphological” signs of aging.
Matrixyl® Inside — A branding initiative used by skincare companies to certify that their products contain genuine Croda Matrixyl peptides.
GB
